OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

SLNCF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Silence Therapeutics (SLNCF) Ownership - Who owns Silence Therapeutics?

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

72 Hammersmith Road

Phone

+44 2034576900

Employees

109

Web

https://www.silence-therapeutics.com

Details

Group

Domestic Stock Funds

Fundamentals

SLNCF

Capitalization

225M

P/E Ratio

N/A

Risk (Beta)

0.19

Dividend Yield

N/A

Total Cash

137M

Total Cash/Share

0.96

Total Debt

60K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.20%

Revenue

27.7M

ROE

N/A

Book Value

-112.74M

P/B Ratio

1.03

Cash Flow

N/A

Earnings

-0.51

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

-10.29M

Current Ratio

8.81

Current Revenue Per Employee

1224.14

Dividends Per Share - Security

N/A

EBITDA

-71.65M

Float

N/A

Float - Current

N/A

Gross Income Margin

61.97

Revenue To Assets

-33.21

Shares Held By Institutions

160

Shares Outstanding - Current

142M

Total Liabilities

298M

Total Volume MTD

N/A

Value

Gain YTD

-39.429

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology